Polycystic ovary syndrome in patients with hair thinning - 19/06/20
Doi : 10.1016/j.jaad.2020.01.075
Sonya Prasad, BA a, Brianna De Souza, MD a, Laura J. Burns, BS a, Margaret Lippincott, MD b, c, Maryanne M. Senna, MD a, b, ⁎ 
a Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts
b Harvard Medical School, Boston, Massachusetts
c Department of Reproductive Endocrinology, Massachusetts General Hospital, Boston, Massachusetts
∗Correspondence to: Maryanne M. Senna, MD, 50 Staniford St, Ste 200, Boston, MA 0211450 Staniford StSte 200BostonMA02114
| Ms Prasad and Dr De Souza are cofirst authors. |
|
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Reviewed and approved by the Partners Healthcare Institutional Review Board (protocol no. 2019P001985). |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 1
P. 260-261 - juillet 2020 Retour au numéro
Article précédent
- Paternal acitretin exposure and the risk of miscarriage and major congenital malformations: A nationwide register-based cohort study
- Mia Noergaard, Stine Soendersted Clausen, Jon Trærup Andersen
- Integrated safety analysis: Frequency of urinary tract infections in patients with psoriasis treated with ixekizumab
- Saxon D. Smith, Curdin Conrad, Michael Ramharter, Alice Benedix Gottlieb, Himanshu Patel, Wen Xu, Elisabeth Riedl, Christopher Schuster
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?